ATX-101, a novel cell-penetrating peptide containing APIM, is a PCNAi that disrupts PCNA-protein interactions and has shown significant anti-cancer activity as a single agent in multiple cancer cell lines and models [232, 245]. This evidence concerns the gene PCNA and cancer.